What's in Fernanda P Silveira, MD, MS's pipeline?

Fernanda P Silveira, MD, MS has 2 drugs in our index: 1 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Fernanda P Silveira, MD, MS's portfolio?

Top competitors by shared drug class: Cidara Therapeutics Inc., Drugs for Neglected Diseases, LI YAN, Novartis, Polichem S.A..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/fernanda-p-silveira-md-ms.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Fernanda P Silveira, MD, MS — Portfolio Competitive Intelligence Brief

Fernanda P Silveira, MD, MS pipeline: 1 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Cytogam	Cytogam	marketed			Other
Standard of care antifungal prophylaxis	Standard of care antifungal prophylaxis	phase 3	Antifungal		Infectious Diseases

Therapeutic area mix

Infectious Diseases · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Cidara Therapeutics Inc. · 1 shared drug class
Drugs for Neglected Diseases · 1 shared drug class
LI YAN · 1 shared drug class
Novartis · 1 shared drug class
Polichem S.A. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Fernanda P Silveira, MD, MS:

Cite this brief

Drug Landscape (2026). Fernanda P Silveira, MD, MS — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/fernanda-p-silveira-md-ms. Accessed 2026-05-16.